Free Trial

Novo Integrated Sciences (NVOS) Insider Trading & Ownership

$0.04 +0.01 (+23.08%)
(As of 12/20/2024 04:19 PM ET)

Novo Integrated Sciences (NASDAQ:NVOS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.40%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$11,150.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get NVOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Novo Integrated Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NVOS Insider Buying and Selling by Quarter

Novo Integrated Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/19/2022Robert Letterio OlivaDirectorBuy500$22.30$11,150.00  
(Data available from 1/1/2013 forward)

NVOS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Novo Integrated Sciences includes Robert Letterio Oliva. Learn more on insiders at NVOS.

10.40% of Novo Integrated Sciences stock is owned by insiders. Learn more on NVOS's insider holdings.

Novo Integrated Sciences Key Executives

  • Mr. Robert Mattacchione (Age 56)
    Chairman of the Board & CEO
    Compensation: $185k
  • Mr. Christopher Mehlin David (Age 65)
    COO & Director
    Compensation: $171k
  • Mr. Robert Letterio Oliva (Age 60)
    President
  • Mr. Vivek Sethi C.A. (Age 38)
    CPA, Principal Financial Officer & Principal Accounting Officer
  • Dr. Joseph M. Chalil FACHE
    M.B.A., M.D., Chief Medical Officer & Chairman of Medical Advisory Board


This page (NASDAQ:NVOS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners